In the past decade, many genes, including Canstatin [34], VEGF [35], drug resistance gene MDR1 [36, 37], stem cell marker CD44 [38], and tumor suppressor p53 [39] have been constructed into vectors for investigation of anti-tumor effects. This evidence concerns the gene TP53 and neoplasm.